Brookmont Capital Management / JNJ
Brookmont Capital Management’s Johnson & Johnson Position
Does Brookmont Capital Management own Johnson & Johnson (JNJ)? Yes — 10.3K shares worth $3M (+1.41% of its 13F portfolio) as of Q1 2026, up from 10.0K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
10.3K
% of Portfolio
+1.41%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 10.3K | $3M | +1.41% |
| Q4 2025 | 10.0K | $2M | +1.20% |
| Q3 2025 | 10.1K | $2M | +1.04% |
| Q2 2025 | 10.6K | $2M | +0.92% |
| Q1 2025 | 10.9K | $2M | +1.02% |
| Q4 2024 | 11.6K | $2M | +0.89% |
| Q3 2024 | 14.6K | $2M | +1.22% |
| Q2 2024 | 14.9K | $2M | +1.19% |
| Q1 2024 | 15.0K | $2M | +1.25% |
| Q4 2023 | 14.9K | $2M | +1.30% |
| Q3 2023 | 14.8K | $2M | +1.44% |
| Q2 2023 | 14.9K | $2M | +1.48% |
| Q1 2023 | 14.9K | $2M | +1.45% |
| Q4 2022 | 14.8K | $3M | +1.61% |
| Q3 2022 | 15.3K | $3M | +1.74% |
| Q2 2022 | 14.4K | $3M | +1.76% |
| Q1 2022 | 14.9K | $3M | +1.59% |
| Q4 2021 | 14.7K | $3M | +1.33% |
| Q3 2021 | 15.3K | $2M | +1.46% |
| Q2 2021 | 15.2K | $3M | +1.52% |
| Q1 2021 | 15.2K | $3M | +1.61% |
| Q4 2020 | 15.5K | $2M | +1.72% |
| Q3 2020 | 16.1K | $2M | +1.78% |
| Q2 2020 | 15.8K | $2M | +1.78% |
| Q1 2020 | 19.9K | $3M | +2.10% |
| Q4 2019 | 20.7K | $3M | +1.80% |
| Q3 2019 | 22.4K | $3M | +1.66% |
| Q2 2019 | 22.6K | $3M | +1.89% |
| Q1 2019 | 22.5K | $3M | +1.93% |
| Q4 2018 | 22.4K | $3M | +1.97% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brookmont Capital Management’s full portfolio or all institutional holders of JNJ.